Full Length Research Paper
References
Department of Health (2013). Management of Drug-resistant Tuberculosis. Draft Policy Guidelines. National Tuberculosis Programme. (3nd ed). | ||||
Department of Health, Republic of South Africa (2011). Management of | ||||
Finlay A, Lancaster J, Holtz TH, Weyer K, Miranda A, van der Walt M (2012). Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study. BMC Public Health 12:56. Crossref |
||||
Holtz TH, Lancaster J, Laserson KF, Wells CD, Thorpe L, Weyer K. (2006). Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001. Int. J. Tuberc. Lung Dis. 10(6):649-55. | ||||
Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, KOH WJ, Lee CH, Shim TS (2010). Treatment outcomes and survival based on drug resistance patterns in multi drug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 182:113-119. Crossref |
||||
Kumar V, Abbas AK, Nelson F, Mitchell RN (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier pp. 516-522. | ||||
Meintjes G (2014). Management of drug-resistant TB in patients with HIV co-infection. Abstracts of the HIV Drug Therapy Glasgow Congress 2014. J. Int. AIDS Soc. 17(Suppl 3):19508. | ||||
Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC (2006). Multidrug-resistant tuberculosis management in resource-limited settings. Emerg. Infect. Dis. 12(9):1389-1397. Crossref |
||||
Pepper DJ, Rebe K, Morroni C, Wilkinson RJ, Meintjes G (2009). Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses. PLoS ONE 4(2):e4520. Crossref |
||||
Sanchez-Padila E, Dlamini T, Ascorra A, Rusch – Gerdes S, Tefera ZD, Calain P, de la Tour R, Jochims F, Richter E, Bonnet M (2012). High Prevalence of Multidrug-resistant Tuberculosis, Swaziland, 2009-2010. J. Emerg. Infect. Dis. 18(1):29-37. Crossref |
||||
Shean KP, Willcox PA, Siwendu SN, Laserson KF, Gross L, Kammerer S, Wells CD, Holtz TH (2008). Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002. Int. J. Tuberc. Lung Dis. 12(10):1182-1189 | ||||
Statistics South Africa (2014). Mortality and causes of death in South Africa, 2013: Findings from death notifications (Statistical Release P0309.3).Available at: www.statssa.goz.za. | ||||
Theron D (2003-2005). Boland/Overberg region, MDR Outcomes 2003-2005, unpublished observations. Brewelskloof Hospital 2003, 2004, 2005 Annual report. | ||||
World Health Organization (2009). Global Tuberculosis Control: Epidemiology, Strategy, Financing. WHO Report 2009. ISBN 98 92 4 156380 2. World Health Organization, Geneva, Switzerland. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0